Boothbay Fund Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History
Bought
Maintained
Sold
Other funds holding LYRA
PA
SM
IC
Boothbay Fund Management's LYRA Position: Q2 2025 in Review
Boothbay Fund Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 4,680 shares — an estimated $29.6K sold.
Boothbay Fund Management first reported a position in LYRA in Q3 2020 and held it in 19 quarters. The position peaked at $1.45M in Q1 2024. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.
- Boothbay Fund Management reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
- Boothbay Fund Management sold 4,680 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $29.6K.
- Boothbay Fund Management first reported a position in LYRA THERAPEUTICS INC in Q3 2020 and held it in 19 quarters.
- Boothbay Fund Management's LYRA THERAPEUTICS INC position peaked at $1.45M in Q1 2024.
- 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.
Based on Boothbay Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.